Ani Pharmaceuticals (ANIP) Capital Expenditures (2010 - 2026)
Ani Pharmaceuticals (ANIP) recorded Capital Expenditures of $3.05 million in Q2 2026, down 23.9% from $4.01 million a year earlier and down 49.7% from the prior quarter.
Ani Pharmaceuticals (ANIP) Capital Expenditures (2010 - 2026) Analysis & Trends
On a TTM basis, Ani Pharmaceuticals' Capital Expenditures came in at $16.48 million as of Jun 30, 2026, up 20.3% year-over-year; for FY2025, it came in at $13.84 million, down 14.8% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $16.24 million in FY2024 (+83.1%), $8.87 million in FY2023 (-0.1%), $8.88 million in FY2022 (+247.1%) and $2.56 million in FY2021 (-58.3%).
- Quarterly Capital Expenditures has ranged from $356,000 in Q4 2021 to $6.1 million in Q3 2025 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in four of the last eight quarters, with growth averaging 28.3%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 781.5% in Q4 2022, against a decline of 83.1% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.07 million (Q1 2026), $1.24 million (Q4 2025) and $6.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 512.62 Mn | 165.89 Mn | 3.05 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.05 Mn |
| Mar 31, 2026 | 6.07 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.50 Mn |
| Mar 31, 2023 | 2.35 Mn |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | 2.47 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 356,000.00 |
| Sep 30, 2021 | 571,000.00 |
Ani Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();